Price
$13.15
Decreased by -0.53%
Dollar volume (20D)
256.62 K
ADR%
13.03
Shares float
792.86 K
Shares short
19.20 K [2.42%]
Shares outstanding
1.61 M
Market cap
2.89 M
Beta
0.46
Price/earnings
N/A
20D range
2.80 14.26
50D range
1.10 14.26
200D range
0.80 14.26

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.

The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates.

The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota.

Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 8, 23 -1.51
Decreased by -77.09%
-
Aug 10, 23 -3.24
Decreased by -575.00%
-4.50
Increased by +28.00%
May 10, 23 -0.38
Increased by +26.92%
-0.09
Decreased by -322.22%
Mar 23, 23 -0.56
Decreased by -40.00%
-0.34
Decreased by -64.71%
Nov 10, 22 -0.85
Decreased by -304.76%
-0.40
Decreased by -112.50%
Aug 11, 22 -0.48
Decreased by -50.00%
-0.41
Decreased by -17.07%
May 16, 22 -0.52
Increased by +48.00%
-
Mar 31, 22 -0.40
Decreased by -42.86%
-0.32
Decreased by -25.00%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 0.00
Decreased by -100.00%
-2.42 M
Increased by +93.98%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by -100.00%
-6.95 M
Increased by +69.48%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 107.00 K
Decreased by -69.77%
-63.94 M
Decreased by -160.40%
Decreased by -59.76 K%
Decreased by -761.52%
Dec 31, 22 8.00 K
Decreased by -99.01%
-26.32 M
Decreased by -38.14%
Decreased by -329.02 K%
Decreased by -13.82 K%
Sep 30, 22 138.00 K
Decreased by -98.78%
-40.11 M
Decreased by -302.91%
Decreased by -29.07 K%
Decreased by -33.02 K%
Jun 30, 22 361.00 K
Decreased by -87.24%
-22.77 M
Decreased by -50.12%
Decreased by -6.31 K%
Decreased by -1.08 K%
Mar 31, 22 354.00 K
Decreased by -90.04%
-24.55 M
Decreased by -75.62%
Decreased by -6.94 K%
Decreased by -1.66 K%
Dec 31, 21 806.00 K
Decreased by -55.40%
-19.05 M
Decreased by -45.56%
Decreased by -2.36 K%
Decreased by -226.33%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY